ProShare Advisors’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$193M Buy
2,104,367
+20,284
+1% +$1.77M 0.28% 58
2026
Q1
$178M Sell
2,084,083
-64,059
-3% -$5.71M 0.26% 59
2025
Q4
$170M Buy
2,148,142
+100,600
+5% +$7.89M 0.3% 79
2025
Q3
$164M Buy
2,047,542
+202,379
+11% +$17.3M 0.34% 86
2025
Q2
$168M Sell
1,845,163
-226,295
-11% -$20.7M 0.33% 88
2025
Q1
$194M Buy
2,071,458
+53,415
+3% +$4.78M 0.44% 55
2024
Q4
$183M Buy
2,018,043
+61,068
+3% +$5.83M 0.42% 71
2024
Q3
$203M Sell
1,956,975
-173,065
-8% -$17.6M 0.5% 56
2024
Q2
$207M Sell
2,130,040
-126,184
-6% -$11.6M 0.55% 38
2024
Q1
$203M Sell
2,256,224
-44,877
-2% -$3.8M 0.54% 48
2023
Q4
$183M Sell
2,301,101
-175,200
-7% -$13.2M 0.56% 58
2023
Q3
$176M Buy
2,476,301
+92,168
+4% +$6.89M 0.55% 49
2023
Q2
$184M Sell
2,384,133
-24,521
-1% -$1.9M 0.53% 54
2023
Q1
$181M Buy
2,408,654
+49,573
+2% +$3.69M 0.55% 49
2022
Q4
$186M Buy
2,359,081
+213,711
+10% +$16M 0.65% 43
2022
Q3
$151M Sell
2,145,370
-17,776
-0.8% -$1.39M 0.58% 51
2022
Q2
$173M Buy
2,163,146
+149,337
+7% +$11.7M 0.57% 41
2022
Q1
$153M Sell
2,013,809
-98,006
-5% -$7.76M 0.33% 85
2021
Q4
$180M Buy
2,111,815
+290,836
+16% +$22.7M 0.35% 58
2021
Q3
$138M Buy
1,820,979
+63,238
+4% +$5.02M 0.39% 79
2021
Q2
$143M Buy
1,757,741
+210,345
+14% +$17.2M 0.42% 58
2021
Q1
$122M Buy
1,547,396
+152,417
+11% +$11.9M 0.38% 80
2020
Q4
$119M Buy
1,394,979
+38,515
+3% +$3.18M 0.44% 50
2020
Q3
$105M Buy
1,356,464
+151,259
+13% +$11.5M 0.48% 51
2020
Q2
$88.3M Sell
1,205,205
-342,343
-22% -$24.3M 0.47% 74
2020
Q1
$103M Sell
1,547,548
-180,146
-10% -$12.7M 0.74% 24
2019
Q4
$119M Buy
1,727,694
+292,018
+20% +$19.9M 0.55% 59
2019
Q3
$106M Buy
1,435,676
+121,163
+9% +$8.79M 0.59% 41
2019
Q2
$94.2M Buy
1,314,513
+47,861
+4% +$3.4M 0.56% 46
2019
Q1
$86.8M Buy
1,266,652
+79,168
+7% +$5.11M 0.52% 49
2018
Q4
$70.7M Buy
1,187,484
+30,466
+3% +$1.91M 0.49% 62
2018
Q3
$77.5M Buy
1,157,018
+64,513
+6% +$4.3M 0.53% 50
2018
Q2
$70.8M Buy
1,092,505
+58,690
+6% +$3.84M 0.47% 59
2018
Q1
$74.1M Sell
1,033,815
-12,935
-1% -$931K 0.48% 53
2017
Q4
$79M Buy
1,046,750
+137,049
+15% +$10M 0.55% 45
2017
Q3
$66.3M Buy
909,701
+47,398
+5% +$3.42M 0.61% 43
2017
Q2
$63.9M Sell
862,303
-17,349
-2% -$1.29M 0.64% 43
2017
Q1
$64.4M Buy
879,652
+79,323
+10% +$5.55M 0.67% 31
2016
Q4
$52.4M Buy
800,329
+64,264
+9% +$4.41M 0.58% 61
2016
Q3
$54.6M Buy
736,065
+62,651
+9% +$4.63M 0.76% 32
2016
Q2
$49.3M Buy
673,414
+172,665
+34% +$12.3M 0.64% 35
2016
Q1
$35.4M Buy
500,749
+71,596
+17% +$4.76M 0.49% 47
2015
Q4
$28.6M Buy
429,153
+64,718
+18% +$4.31M 0.35% 68
2015
Q3
$23.1M Buy
364,435
+52,283
+17% +$3.42M 0.32% 68
2015
Q2
$20.4M Sell
312,152
-5,461
-2% -$370K 0.28% 77
2015
Q1
$22M Buy
317,613
+46,421
+17% +$3.21M 0.26% 78
2014
Q4
$18.8M Buy
271,192
+75,141
+38% +$5.07M 0.22% 93
2014
Q3
$12.8M Buy
196,051
+959
+0.5% +$63.3K 0.17% 102
2014
Q2
$13.3M Buy
195,092
+10,907
+6% +$731K 0.17% 102
2014
Q1
$11.9M Buy
184,185
+23,852
+15% +$1.5M 0.15% 113
2013
Q4
$10.5M Buy
160,333
+96,617
+152% +$6.18M 0.16% 118
2013
Q3
$3.78M Sell
63,716
-63,438
-50% -$3.76M 0.09% 178
2013
Q2
$7.29M Buy
+127,154
New +$7.55M 0.14% 125

Other funds holding CL

ProShare Advisors's CL Position: Q2 2026 in Review

ProShare Advisors increased its Colgate-Palmolive (CL) stake by 0.97% in Q2 2026, buying an estimated $1.77M and bringing the position to 2,104,367 shares worth $193M. The position accounts for 0.28% of the portfolio, ranked #58.

ProShare Advisors first reported a position in CL in Q2 2013 and has held it in 53 quarters since. The position peaked at $207M in Q2 2024. 2,011 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • ProShare Advisors held 2,104,367 shares of Colgate-Palmolive worth $193M as of Q2 2026.
  • ProShare Advisors bought 20,284 Colgate-Palmolive shares in Q2 2026, an estimated $1.77M.
  • Colgate-Palmolive made up 0.28% of ProShare Advisors's portfolio in Q2 2026, its #58 holding.
  • ProShare Advisors first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 53 quarters since.
  • ProShare Advisors's Colgate-Palmolive position peaked at $207M in Q2 2024.
  • 2,011 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on ProShare Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.